HDPs, including preeclampsia, superimposed preeclampsia, chronic hypertension, gestational hypertension, Hemolysis, Elevated Liver enzymes and Low Platelets (HELLP) syndrome, and eclampsia, are the leading cause of maternal and infant illness and death in the United States. Continue Reading
News
Journalists working on stories related to high-risk pregnancies or the Society for Maternal-Fetal Medicine can contact Greg Phillips, Director of Communications, at press@smfm.org for referrals to MFM experts and to request additional information. The press office is open Monday through Friday from 9:00 AM to 5:00 PM ET.
Prescribing daily aspirin at the first prenatal visit to all pregnant patients was associated with an overall reduction in the development of severe preeclampsia, according to new research presented today at the Society for Maternal-Fetal Medicine (SMFM) 2026 Pregnancy Meeting™. Continue Reading
Coding Tip: Billing and Documentation for Fetal Nonstress Tests (NSTs) The Society for Maternal-Fetal Medicine (SMFM) Coding Committee; Trisha Malisch, CCS-P, CPC, COBGC; Robert Rossi, MD; Barbra Fisher, MD, PhD Introduction Fetal nonstress tests (NSTs) are one of the most frequently used... Continue Reading
National Harbor, MD. ― Hypertensive disorders of pregnancy (HDP) and gestational diabetes (GDM) are twoof the most common pregnancy complications and put pregnant people at increased risk of developingcardiovascular disease later in life.Now, in a new study to be presented today at the Society for... Continue Reading